GTR Home > Tests > Search results - AGA[gene]

Apply filters

Showing tests for all 2076 conditions

Compare labs

Your search term can be found in tests with a total of 2076 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states

GTR test search results for 175[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 27 tests for 2076 conditions in 17 labs

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CAGA Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAGA Prenatal Sequence Analysis

Test targets
Methods
  • E Sequence analysis of select exons

CAGA Familial Mutation/Variant Analysis

Test targets
Methods
  • E Sequence analysis of select exons

CAspartylglucosaminuria via the AGA Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CAspartylglycosaminuria

Lab: Counsyl South San Francisco, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (620)
Total targets (421)

CSevere Recessive Childhood Diseases

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (436)

CMetabolic Storage Disorders Panel Sequencing, 51 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (57)
Total targets (51)

CAGA

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLysosomal Storage Disorders: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (88)
Total targets (55)

CLysosomal Disorders NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (193)
Total targets (106)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (598)
Total targets (343)

CAspartylglucosaminuria: AGA Full Gene Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAspartylglycosaminuria

Test targets
Methods
  • C Sequence analysis of the entire coding region

Caspartylglucose aminididase gene Finnish mutation analysis

Lab: Laboratory of Genetics HUSLAB Helsinki, Southern Finland, Finland
Test targets
Methods
  • T Targeted variant analysis

CTest for Aspartylglycosaminuria

Lab: GeneDx Gaithersburg, MD, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

Showing 1 to 20 of 27 tests for 2076 conditions in 17 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk